Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.

Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM.

Parkinsonism Relat Disord. 2019 Aug;65:172-177. doi: 10.1016/j.parkreldis.2019.06.018. Epub 2019 Jun 23.

PMID:
31253494
2.

Framing advance care planning in Parkinson disease: Patient and care partner perspectives.

Lum HD, Jordan SR, Brungardt A, Ayele R, Katz M, Miyasaki JM, Hall A, Jones J, Kluger B.

Neurology. 2019 May 28;92(22):e2571-e2579. doi: 10.1212/WNL.0000000000007552. Epub 2019 Apr 26.

PMID:
31028124
3.

Reader response: Demoralization in Parkinson disease.

Bruno V, Mancini D, Zurowski M, Miyasaki JM.

Neurology. 2018 Nov 27;91(22):1029. doi: 10.1212/WNL.0000000000006568. No abstract available.

PMID:
30478072
4.

Age and sex differences in burnout, career satisfaction, and well-being in US neurologists.

LaFaver K, Miyasaki JM, Keran CM, Rheaume C, Gulya L, Levin KH, Jones EC, Schwarz HB, Molano JR, Hessler A, Singhal D, Shanafelt TD, Sloan JA, Novotny PJ, Cascino TL, Busis NA.

Neurology. 2018 Nov 13;91(20):e1928-e1941. doi: 10.1212/WNL.0000000000006497. Epub 2018 Oct 10.

PMID:
30305448
5.

Top Ten Tips Palliative Care Clinicians Should Know About Parkinson's Disease and Related Disorders.

Katz M, Goto Y, Kluger BM, Galifianakis NB, Miyasaki JM, Kutner JS, Jones CA, Pantilat SZ.

J Palliat Med. 2018 Oct;21(10):1507-1517. doi: 10.1089/jpm.2018.0390. Epub 2018 Sep 11.

PMID:
30204543
6.

A Mixed-Methods Approach to Understanding the Palliative Needs of Parkinson's Patients.

Prizer LP, Gay JL, Wilson MG, Emerson KG, Glass AP, Miyasaki JM, Perkins MM.

J Appl Gerontol. 2018 May 1:733464818776794. doi: 10.1177/0733464818776794. [Epub ahead of print]

PMID:
29788783
7.

Author response: Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016.

Miyasaki JM, Rheaume C, Gulya L, Ellenstein A, Schwarz H, Vidic T, Shanafelt T, Cascino T, Keran C, Busis N.

Neurology. 2018 May 8;90(19):903. doi: 10.1212/WNL.0000000000005487. No abstract available.

PMID:
29735774
8.

Author response: Burnout, career satisfaction, and well-being among US neurologists in 2016.

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL.

Neurology. 2017 Oct 10;89(15):1650-1651. doi: 10.1212/WNL.0000000000004484. Epub 2017 Oct 9. No abstract available.

PMID:
28993531
9.

Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016.

Miyasaki JM, Rheaume C, Gulya L, Ellenstein A, Schwarz HB, Vidic TR, Shanafelt TD, Cascino TL, Keran CM, Busis NA.

Neurology. 2017 Oct 17;89(16):1730-1738. doi: 10.1212/WNL.0000000000004526. Epub 2017 Sep 20.

PMID:
28931640
10.

Treatable inherited rare movement disorders.

Jinnah HA, Albanese A, Bhatia KP, Cardoso F, Da Prat G, de Koning TJ, Espay AJ, Fung V, Garcia-Ruiz PJ, Gershanik O, Jankovic J, Kaji R, Kotschet K, Marras C, Miyasaki JM, Morgante F, Munchau A, Pal PK, Rodriguez Oroz MC, Rodríguez-Violante M, Schöls L, Stamelou M, Tijssen M, Uribe Roca C, de la Cerda A, Gatto EM; International Parkinson's Disease Movement Disorders Society Task Force on Rare Movement Disorders.

Mov Disord. 2018 Jan;33(1):21-35. doi: 10.1002/mds.27140. Epub 2017 Sep 1. Review.

11.

Treatment gaps in Parkinson's disease care in the Philippines.

Jamora RDG, Miyasaki JM.

Neurodegener Dis Manag. 2017 Aug;7(4):245-251. doi: 10.2217/nmt-2017-0014. Epub 2017 Aug 30. Review.

PMID:
28853633
12.

Using social exchange theory to understand non-terminal palliative care referral practices for Parkinson's disease patients.

Prizer LP, Gay JL, Perkins MM, Wilson MG, Emerson KG, Glass AP, Miyasaki JM.

Palliat Med. 2017 Oct;31(9):861-867. doi: 10.1177/0269216317701383. Epub 2017 Mar 22.

PMID:
28659011
13.

Decisional capacity for advanced care directives in Parkinson's disease with cognitive concerns.

Abu Snineh M, Camicioli R, Miyasaki JM.

Parkinsonism Relat Disord. 2017 Jun;39:77-79. doi: 10.1016/j.parkreldis.2017.03.006. Epub 2017 Mar 8.

PMID:
28336349
14.

Burnout, career satisfaction, and well-being among US neurologists in 2016.

Busis NA, Shanafelt TD, Keran CM, Levin KH, Schwarz HB, Molano JR, Vidic TR, Kass JS, Miyasaki JM, Sloan JA, Cascino TL.

Neurology. 2017 Feb 21;88(8):797-808. doi: 10.1212/WNL.0000000000003640. Epub 2017 Jan 25.

15.

Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism.

Bruno VA, Fox SH, Mancini D, Miyasaki JM.

Can J Neurol Sci. 2016 Sep;43(5):697-702. doi: 10.1017/cjn.2016.279. Epub 2016 Aug 12.

PMID:
27514242
16.

Treatment of Advanced Parkinson Disease and Related Disorders.

Miyasaki JM.

Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1104-16. doi: 10.1212/CON.0000000000000347. Review.

PMID:
27495200
17.

New insights into the neural basis of functional movement disorders.

Planetta PJ, Miyasaki JM.

Neurology. 2016 Aug 9;87(6):554-5. doi: 10.1212/WNL.0000000000002957. Epub 2016 Jul 6. No abstract available.

PMID:
27385748
18.

Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary.

Factor SA, Bennett A, Hohler AD, Wang D, Miyasaki JM.

Neurology. 2016 Jun 14;86(24):2278-83. doi: 10.1212/WNL.0000000000002670. Epub 2016 May 11. No abstract available.

19.

High prevalence of physical and sexual aggression to caregivers in advanced Parkinson's disease. Experience in the Palliative Care Program.

Bruno V, Mancini D, Ghoche R, Arshinoff R, Miyasaki JM.

Parkinsonism Relat Disord. 2016 Mar;24:141-2. doi: 10.1016/j.parkreldis.2016.01.010. Epub 2016 Jan 11. No abstract available.

PMID:
26786755
20.

Palliative care for Parkinson's disease: has the time come?

Miyasaki JM, Kluger B.

Curr Neurol Neurosci Rep. 2015 May;15(5):26. doi: 10.1007/s11910-015-0542-4. Review.

PMID:
25795037
21.

The Profile of Long-term Parkinson's Disease Survivors with 20 Years of Disease Duration and Beyond.

Hassan A, Wu SS, Schmidt P, Simuni T, Giladi N, Miyasaki JM, Bloem BR, Malaty IA, Okun MS.

J Parkinsons Dis. 2015;5(2):313-9. doi: 10.3233/JPD-140515.

PMID:
25720446
22.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
23.

Movement disorders in pregnancy.

Miyasaki JM, Aldakheel A.

Continuum (Minneap Minn). 2014 Feb;20(1 Neurology of Pregnancy):148-61. doi: 10.1212/01.CON.0000443842.18063.a9. Review.

PMID:
24492816
24.

Mobility, mood and site of care impact health related quality of life in Parkinson's disease.

Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC; National Parkinson Foundation Quality Improvement Initiative Investigators.

Parkinsonism Relat Disord. 2014 Mar;20(3):274-9. doi: 10.1016/j.parkreldis.2013.10.004. Epub 2013 Oct 16.

PMID:
24182524
25.

Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice.

Keller A, Westenberger A, Sobrido MJ, García-Murias M, Domingo A, Sears RL, Lemos RR, Ordoñez-Ugalde A, Nicolas G, da Cunha JE, Rushing EJ, Hugelshofer M, Wurnig MC, Kaech A, Reimann R, Lohmann K, Dobričić V, Carracedo A, Petrović I, Miyasaki JM, Abakumova I, Mäe MA, Raschperger E, Zatz M, Zschiedrich K, Klepper J, Spiteri E, Prieto JM, Navas I, Preuss M, Dering C, Janković M, Paucar M, Svenningsson P, Saliminejad K, Khorshid HR, Novaković I, Aguzzi A, Boss A, Le Ber I, Defer G, Hannequin D, Kostić VS, Campion D, Geschwind DH, Coppola G, Betsholtz C, Klein C, Oliveira JR.

Nat Genet. 2013 Sep;45(9):1077-82. doi: 10.1038/ng.2723. Epub 2013 Aug 4.

PMID:
23913003
26.

Palliative care in Parkinson's disease.

Miyasaki JM.

Curr Neurol Neurosci Rep. 2013 Aug;13(8):367. doi: 10.1007/s11910-013-0367-y.

PMID:
23761129
27.

Which dyskinesia scale best detects treatment response?

Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S.

Mov Disord. 2013 Mar;28(3):341-6. doi: 10.1002/mds.25321. Epub 2013 Feb 6.

PMID:
23390076
28.

The emerging field of palliative care for Parkinson's disease. Letter from the guest editors.

Miyasaki JM, Okun MS.

Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S1. doi: 10.1016/j.parkreldis.2012.10.012. No abstract available.

PMID:
23206368
29.

Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD.

Miyasaki JM, Long J, Mancini D, Moro E, Fox SH, Lang AE, Marras C, Chen R, Strafella A, Arshinoff R, Ghoche R, Hui J.

Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S6-9. doi: 10.1016/j.parkreldis.2012.06.013. Epub 2012 Aug 3.

PMID:
22867994
30.

Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Armstrong MJ, Miyasaki JM; American Academy of Neurology.

Neurology. 2012 Aug 7;79(6):597-603. doi: 10.1212/WNL.0b013e318263c443. Epub 2012 Jul 18.

31.

What are the issues facing Parkinson's disease patients at ten years of disease and beyond? Data from the NPF-QII study.

Hassan A, Wu SS, Schmidt P, Malaty IA, Dai YF, Miyasaki JM, Okun MS.

Parkinsonism Relat Disord. 2012 Dec;18 Suppl 3:S10-4. doi: 10.1016/j.parkreldis.2012.06.014. Epub 2012 Jul 7.

PMID:
22776044
32.

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, Antonelli F, Houle S, Lang AE, Strafella AP.

Neurobiol Dis. 2012 Dec;48(3):519-25. doi: 10.1016/j.nbd.2012.06.021. Epub 2012 Jul 3.

33.

Chorea caused by toxins.

Miyasaki JM.

Handb Clin Neurol. 2011;100:335-46. doi: 10.1016/B978-0-444-52014-2.00026-4. Review.

PMID:
21496593
34.

Evidence-based initiation of dopaminergic therapy in Parkinson's disease.

Miyasaki JM.

J Neurol. 2010 Nov;257(Suppl 2):S309-13. doi: 10.1007/s00415-010-5718-x. Review.

PMID:
21080195
35.

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD.

van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, Miyasaki JM, Zurowski M, Lang AE, Strafella AP.

Neurology. 2010 Nov 9;75(19):1711-6. doi: 10.1212/WNL.0b013e3181fc27fa. Epub 2010 Oct 6.

36.

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2010 May 4;74(18):1463-70. doi: 10.1212/WNL.0b013e3181dc1ae0. Review.

37.

Using evidence-based medicine in neurology.

Miyasaki JM.

Neurol Clin. 2010 May;28(2):489-503. doi: 10.1016/j.ncl.2009.11.010.

PMID:
20202506
38.

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?

van Eimeren T, Ballanger B, Pellecchia G, Miyasaki JM, Lang AE, Strafella AP.

Neuropsychopharmacology. 2009 Dec;34(13):2758-66. doi: 10.1038/sj.npp.npp2009124. Epub 2009 Sep 9.

39.

Impulse control and related disorders in Parkinson's disease: review.

Lim SY, Evans AH, Miyasaki JM.

Ann N Y Acad Sci. 2008 Oct;1142:85-107. doi: 10.1196/annals.1444.006. Review.

PMID:
18990123
40.

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2008 May 6;70(19):1699-706. doi: 10.1212/01.wnl.0000311389.26145.95.

41.

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Neurology. 2008 May 6;70(19):1691-8. doi: 10.1212/01.wnl.0000311391.00944.c4.

PMID:
18458229
42.

Invited article: Neurology and quality improvement: an introduction.

Bever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC.

Neurology. 2008 Apr 29;70(18):1636-40. doi: 10.1212/01.wnl.0000310989.84987.88. No abstract available.

PMID:
18443315
43.

Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.

Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E.

Mov Disord. 2007 May 15;22(7):990-7.

PMID:
17443692
44.

Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M.

Arch Neurol. 2007 Feb;64(2):212-6.

PMID:
17296836
45.

Long-term outcome of bilateral pallidal deep brain stimulation for primary cervical dystonia.

Hung SW, Hamani C, Lozano AM, Poon YY, Piboolnurak P, Miyasaki JM, Lang AE, Dostrovsky JO, Hutchison WD, Moro E.

Neurology. 2007 Feb 6;68(6):457-9.

PMID:
17283323
46.

Punding prevalence in Parkinson's disease.

Miyasaki JM, Al Hassan K, Lang AE, Voon V.

Mov Disord. 2007 Jun 15;22(8):1179-81.

PMID:
17230464
47.

New practice parameters in Parkinson's disease.

Miyasaki JM.

Nat Clin Pract Neurol. 2006 Dec;2(12):638-9. No abstract available.

PMID:
17117162
48.

Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, Shulman LM, Gronseth G, Weiner WJ; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2006 Apr 11;66(7):996-1002.

PMID:
16606910
49.

Psychogenic movement disorders.

Miyasaki JM, Sa DS, Galvez-Jimenez N, Lang AE.

Can J Neurol Sci. 2003 Mar;30 Suppl 1:S94-100. Review.

PMID:
12691482
50.

Supplemental Content

Loading ...
Support Center